Key result
Severe elderly heart failure links to ~15-fold higher NT-proBNP levels versus mild disease.
Why the study?
The role of NT-proBNP levels in determining the classification of heart failure severity in elderly patients remains unclear.
Are NT-proBNP levels associated with the severity of heart failure in elderly patients?
Cross-Sectional (n=24)
No
Are NT-proBNP levels associated with the severity of heart failure in elderly patients?
Absolute Event Rate: 12587.58% vs 867.83%
p-value: p=0.040
NT-proBNP levels are significantly higher in elderly patients with severe heart failure (NYHA III-IV) compared to those with mild heart failure (NYHA I-II), supporting its utility in assessing disease severity.
Supports NT-proBNP for severity assessment in elderly HF; hypothesis-generating, needs prospective validation before guiding care.
Background: Heart failure is a major health problem in the world. It is associated with high morbidity and high mortality especially in elderly patients. Most studies reported using N terminal pro-B type natriuretic peptide (NT-proBNP) in diagnosis of heart failure, but about of these tests in determining classification of severity of heart failure in the elderly remain unclear.Objective: To determine the differences NT-pro BNP levels based on the severity of diease of heart failure in elderly patients.Methods: This is an observational study with cross sectional design. Subjects were patients with diagnosed heart failure and aged = 60 years. Patients were divided into two groups, mild and severe heart failure groups according to severity of heart failure in New York Heart Association (NYHA) class. The NT Pro-BNP levels were measured for all subjects in both groups. Data was analyzed with using unpaired t test and was considered significant if p Results: This study involved 24 subjects, consisting of 2 gorups, there were mild heart failure groups (NYHA class I-II) and groups of patients with severe heart failure (NYHA III-IV). The mean age of the subjects was 64.50 ± 4.65 years with a minimum age of 60 years and a maximum of 78 years. The NT pro-BNP levels in the severe heart failure group (1.2587.58 ± 574.85 pg / ml) was higher than the mild heart failure group (867.83 ± 333.27 pg / ml), it was statistically significant with p = 0.040.Conclusion: The levels of NT-pro BNP serum in elderly patients with severe heart failure (NYHA III-IV) were significantly higher than in patients with mild heart failure (NYHA I-II).
No takes yet. Share an insight, caveat, or question.
Marfianti et al. (2020) conducted a cross-sectional in Heart failure (n=24). Severe heart failure (NYHA III-IV) vs. Mild heart failure (NYHA I-II) was evaluated on NT-pro BNP levels (p=0.040). Severe heart failure (NYHA III-IV) in elderly patients was associated with significantly higher NT-pro BNP levels (12,587.58 pg/ml) compared to mild heart failure (867.83 pg/ml, p=0.040).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: